Over the last several months the heat around #EpiGate has been building. Mylan, the pharmaceutical company that owns the EpiPen emergency allergy treatment, has had to defend its price increases on […]
Over the last several months the heat around #EpiGate has been building. Mylan, the pharmaceutical company that owns the EpiPen emergency allergy treatment, has had to defend its price increases on […]